Role of Increased Cerebral myo-Inositol in the Dementia of Down Syndrome
β Scribed by Truda Shonk; Brian D. Ross
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 364 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0740-3194
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The purpose of this study was to determine cerebral myoβinositol (ml) in adults with Down syndrome (DS), and to trace the chronobiology of DS to Alzheimer disease (AD). AD has characteristic neuropathology of neurofibrillary plaques and tangles; indirect evidence links this to earlier deposition of Ξ²βamyloid. Elevated ml, which distinguishes AD from other common dementias, is also elevated in 23 young patients who have DS without dementia. In one patient who has DS with dementia, ml is elevated and Nβacetylaspartate (NAA) decreased. The similarity to AD is striking and may suggest a progressive neurochemical disorder in which elevation of ml precede loss of NAA in both AD and DS.
π SIMILAR VOLUMES
## Abstract The diagnosis of dementia in people with Down syndrome (DS) remains controversial. In this study DS patients who had a diagnosis of clinical dementia according to modified DSMβIIIβR criteria were assessed using the flash (P2) and patternβreversal (P100) visual evoked potential (VEP). Ab
As people with Down syndrome (DS) age, they are at greater risk for Alzheimer disease (AD) than the general population. It has been suggested that polymorphisms at the genes for presenilin-1 (PS-1) and β£-1antichymotrypsin (ACT) confer an increased risk for AD in the general population, and therefore
In a study of amniotic fluid from 91 Down syndrome cases and 240 controls, we have shown that the median value of CA125 in pregnancies affected by Down syndrome on the whole reflects those observed in the maternal serum from 106 affected cases and 238 controls. The median MOM for CA125 in amniotic f
## Abstract ## Objective Virtually all adults with Down syndrome (DS) have neuropathological manifestations of Dementia in Alzheimer's disease (DAD) but not all develop clinical psychopathology. The effect of allelic variants of Apolipoprotein (APOE) gene in development and progression of DAD and